OXGN Key Stats
- OXiGENE Announces Full Year 2013 Earnings Conference Call and Webcast noodls 03/04 06:37 ET
- Nasdaq stocks posting largest volume increases Yahoo 02/21 18:06 ET
- OXIGENE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits Yahoo 02/14 17:05 ET
- Unusual 11 Mid-Day Movers 02/12: (LIVE) (OPTT) (CNVR) Higher; (VTUS) (PGRX) (OXGN) Lower Street Insider 02/12 13:09 ET
- 8:57 am OXiGENE enters into definitive agreements with investors to purchase an aggregate of ~ $12 mln of units, in a registered public offering, at a price per unit of $2.05 Yahoo 02/12 11:56 ET
- OXiGENE, Inc. Announces $12 Million Public Offering noodls 02/12 10:44 ET
- OXIGENE (OXGN) Raises $12M in Equity Offering Street Insider 02/12 08:59 ET
- OXIGENE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Yahoo 02/03 16:47 ET
- OXiGENE Announces Presentation at BIO CEO Conference on February 11th noodls 01/30 07:28 ET
- OXIGENE INC Files SEC form 8-K, Other Events Yahoo 01/13 11:15 ET
|Mar 18||Earnings||OxiGene, Inc. Q4 2013 Earnings Results.|
|Mar 18||Earnings||OxiGene, Inc. Q4 2013 Earnings Conference Call. 4:30 PM EDT|
OXGN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). OxiGene is down 46.15% over the last year vs S&P 500 Total Return up 24.21%, Aastrom Biosciences down 86.88%, and Agenus down 1.79%.
Balance Sheet View Statement
Pro Ratings for OXGN
Pro Strategies Featuring OXGN
Did OxiGene make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: United States
- Headquarters State/Province: California
- Incorporation Country: United States
- Incorporation State/Province: Delaware
OxiGene, Inc is a clinical-stage, biopharmaceutical company that develops novel therapeutics to treat cancer and eye diseases.